Advertisement

Hormonersatztherapie und Alzheimer-Demenz

  • Petra StuteEmail author
Journal Club
  • 3 Downloads

Hormone replacement therapy and Alzheimer’s dementia

Notes

Interessenkonflikt

P. Stute gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Irvine K, Laws KR, Gale TM, Kondel TK (2012) Greater cognitive deterioration in women than men with Alzheimer’s disease: a meta analysis. J Clin Exp Neuropsychol 34(9):989–998CrossRefGoogle Scholar
  2. 2.
    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH (2004) Women’s health initiative memory study, conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women’s health initiative memory study. JAMA 291(24):2947–2958CrossRefGoogle Scholar
  3. 3.
    Maki PM (2013) Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause 20(6):695–709CrossRefGoogle Scholar
  4. 4.
    Henderson VW (2014) Alzheimer’s disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol 142:99–106CrossRefGoogle Scholar
  5. 5.
    Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, Shumaker SA, Espeland MA, Wactawski-Wende J, W.H.I. Investigators (2017) Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women’s health initiative randomized trials. JAMA 318(10):927–938CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Gynäkologische Endokrinologie und ReproduktionsmedizinInselspital BernBernSchweiz

Personalised recommendations